CITED CLIPS
Psychedelics and Depression
Psilocybin shows promise in treating major depression, often providing relief through immersive experiences in controlled settings. While microdosing is discussed, it appears less impactful compared to higher doses administered during clinical sessions. The underlying mechanisms involve neuroplasticity and a complex interplay of neurotransmitters, suggesting that individual responses to psychedelics may vary significantly.In this clip
From this podcast
Huberman Lab
Understanding & Conquering Depression | Huberman Lab Podcast #34
Related Questions
Why is the combined SR form of ketamine the most effective for treating depression?
What does the clinical evidence say about ketamine for treating depression as discussed in the episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity | Huberman Lab Podcast and the clip Ketamine's Dual Action?
What does the clinical evidence say about ketamine for treating depression?